| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |